Reporter brief
Effects of Metformin on Longevity Gene Expression and Inflammation and Prediabetic Individuals. A Placebo-controlled Trial
What happened
Trial registry update: COMPLETED. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- This is a protocol abstract with no outcome data reported, so no effects can be established
- Gene expression changes in blood cells do not establish clinical benefits or effects on actual aging or lifespan
- The study does not report sample size, effect sizes, or statistical significance for any measured outcomes
Study design and sample
Rct; Human.
Pre-diabetic individuals
- Design
- Rct
- Sample
- —
- Journal
- University of Padova
- Published
- Mar 13, 2013
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Metformin timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.